NVP-QAV-572(957209-68-6)
- Name: NVP-QAV-572
- Synonyms:NVP-QAV-572;
- Molecular Formula:C17H19F2N7O3S2
- Molecular Weight:471.512
- CAS Registry Number:957209-68-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.957209-68-6 SAGECHEM/NVP-QAV-572/SAGECHEM/Manufacturer in China
Assay:99% Appearance:SAGECHEM/NVP-QAV-572/SAGECHEM/Manufacturer in China Package:packing on demand Storage:normal temperature Transportation:BY EXPRESS, AIR OR SEA Application:intermediate
Min. Order:0
Supplier:SAGECHEM LIMITED [
China (Mainland)]
CAS No.957209-68-6 NVP-QAV-572
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:NVP-QAV-572
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.957209-68-6 Nvp-qav-572
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
CAS No.957209-68-6 NVP-QAV-572 CAS No.957209-68-6
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]
CAS No.957209-68-6 NVP-QAV-572
Assay:>98% Package:inquiry Transportation:inquiry Application:NVP-QAV-572 is a potent PI3K kianse inhibitor.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 872404-91-6/1-Tert-Butoxycarbonyl-1H-indole-3-acetamide
- 128387-35-9/(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
- 98361-56-9/(1S,2S)-2-((R)-1-phenylethylaMino)cyclohexanol
- 374795-42-3/1-Oxa-9-azaspiro[5.5]undecane-9-carboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester
- 1108147-88-1/MCOPPB (triHydrochloride)
- 1087740-50-8/2,6-Diazaspiro[3.3]heptane, (Hydrochloride), hydrate (1:2:2)
- 1276666-12-6/4-((2-aminoethyl)(5-chlorobenzo[d]oxazol-2-yl)amino)butan-2-one (dimethanesulfonate)
- 915385-81-8/ABC294640
- 1415560-69-8/PF 02341066 hydrochloride
- 1173900-38-3/(S)-methyl 2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoate
- 1380575-43-8/LDK-378 dihydrochloride
- 23491-55-6/Hoechst 33258 analog 5
- 23554-98-5/Hoechst 33258 analog 3
- 1131042-11-9/GSK1720070
- 897732-93-3/JNJ-38431055
- 255374-90-4/WX-UK1
- 701909-57-1/XEN-2174
- 1095173-27-5/PF 04449913
- 1207358-59-5/mTOR inhibitor
- 957209-68-6/NVP-QAV-572
- 1269440-17-6/Encorafenib (LGX818)
- 1251533-99-9/N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide
- 1305115-80-3/PF-04957325
- 1085703-32-7/VITAMIN CK3
- 1133432-49-1/GDC0834
- 882759-86-6/Alanine, N,N'-[[5-[2-amino-5-(2,2-dimethyl-1-oxopropyl)-4-thiazolyl]-2-furanyl]pho sphinylidene]bis[2-methyl-, diethyl ester, monomethanesulfonate
- 191801-19-1/BAL-9602
- 945771-74-4/BNC105
- 942149-56-6/DM-CHOC-PEN
- 603288-22-8/LY2090314